Most kidney transplant recipients settle into a GFR somewhere in the range of 50 to 60 mL/min/1.73 m² by the one-year mark, though the number that counts as “good” for you depends heavily on who donated the kidney, how large the organ is relative to your body, and how the first few weeks after surgery went. A single transplanted kidney simply cannot match the filtering power of two healthy native kidneys, so the goal is not a perfect score but rather a stable, functional level that keeps you off dialysis and feeling well. Understanding where your GFR should land, what shapes it, and when a change signals trouble is one of the most useful things you can learn as a transplant recipient.
The Typical One-Year Benchmark
The largest dataset on post-transplant kidney function in the United States shows that average one-year GFR for deceased-donor recipients has hovered around 55 to 57 mL/min/1.73 m² over the past two decades, with living-donor recipients landing in a similar though slightly higher band.1PubMed Central. Understanding Trends in Kidney Function 1 Year after Kidney Transplant in the United States In clinical terms, that places most transplant recipients in CKD stage 3a (GFR 45–59) or the low end of stage 2 (GFR 60–89). That may sound alarming if you are accustomed to thinking of stage 3 kidney disease as serious, but in a transplant context it is both expected and compatible with decades of good graft function. Your transplant team is not trying to get you to 90 or 100. They are aiming for a number that is stable and keeps you well.
Why a Transplanted Kidney Cannot Hit “Normal”
You are working with one kidney instead of two, so the math alone explains a lot. A single healthy kidney from a young donor typically filters at about 50 to 70 percent of what a pair of kidneys would. The transplanted organ compensates through a process called compensatory hypertrophy: it physically grows larger and its individual filtering units work harder to pick up the slack. Animal studies have shown that a transplanted kidney undergoes the same degree of compensatory growth as a kidney left behind after surgical removal of the other one.2PubMed. Reversible compensatory hypertrophy in transplanted brown Norway rat kidneys That extra effort is helpful in the short run but carries a theoretical long-term cost: the individual filtering units may eventually wear out faster because of the sustained high workload.3PubMed. The hyperfiltration hypothesis in human renal transplantation
This is part of why transplant teams monitor you for years, not just months. The kidney is doing a heroic job from day one, and the question is always whether that effort remains sustainable over time.
How Donor Characteristics Shape Your Number
One of the biggest determinants of your post-transplant GFR is who gave you the kidney. Donor age matters a great deal. Kidneys from older donors start with fewer functional filtering units and less reserve capacity, which translates directly into lower post-transplant GFR. Recipients of kidneys from deceased donors over age 65 had a median one-year GFR of only about 39 mL/min, with the vast majority falling into CKD stages 3a, 3b, or worse.4PubMed Central. US deceased kidney transplantation: Estimated GFR, donor age and KDPI association with graft survival That is a far cry from the 55-plus range seen with younger donors, and it does not necessarily mean the transplant is failing. It means the organ came with less capacity to begin with.
Living donors follow a similar pattern. Research tracking living-donor transplants found that kidneys from older living donors had lower pre-donation GFR, recovered function more slowly in the first few days after surgery, and began declining faster after the first year compared with kidneys from younger donors.5American Journal of Transplantation. Influence of Living Donor Age on Quality of Life and Kidney Transplant Outcomes If you received a kidney from a parent or older relative, a somewhat lower baseline GFR is expected, and your team will factor that into how they interpret your lab results.
Donor kidney function before transplant also independently predicts outcomes. Studies of both related and unrelated living-donor transplants have confirmed that the donor’s own estimated GFR before the surgery is a significant risk factor for how well the graft performs afterward.6Clinical Transplantation. Impact of donor kidney function and donor age on poor outcome of living-unrelated kidney transplantation (KT) in comparison with living-related KT
When the Kidney Is Too Small for the Recipient
Size matters in ways that are easy to overlook. If the donated kidney is small relative to your body, it has to work proportionally harder to filter your blood volume. A systematic review looking at donor-recipient size mismatch found that an unfavorable mismatch was associated with worse outcomes in the majority of studies examined, including lower graft survival and lower GFR.7Transplantation Reviews. Impact of donor-recipient size mismatch on post-transplant outcomes in kidney transplant recipients: A systematic review On the other hand, receiving a kidney from a larger donor appears protective. One study found that recipients who got a kidney from a larger donor had a slower decline in GFR over time compared with those who received a smaller organ.8Transplantation. Impact of donor-recipient body surface area mismatch on kidney graft survival and function
This is especially relevant in female-to-male transplants, where the donor kidney may be meaningfully smaller than what the recipient’s body demands. Research has linked this kind of mismatch to greater kidney and glomerular hypertrophy, which can affect long-term graft function and survival.9PubMed. Correlation of whole kidney hypertrophy with glomerular over-filtration in live, gender-mismatched renal transplant allografts None of this is within your control as a recipient, but it helps explain why two people who received transplants on the same day can have very different GFR numbers.
The First Weeks and Delayed Graft Function
Not every transplanted kidney wakes up immediately. Delayed graft function, where the kidney takes days or weeks to start filtering adequately, is common with deceased-donor transplants and can shape your GFR trajectory for years. Recipients who experience it tend to have a one-year GFR that is roughly 7 mL/min lower than those whose kidneys started working right away.10PubMed Central. Delayed graft function phenotypes and 12-month kidney transplant outcomes
What matters even more than whether delayed graft function happens is how completely the kidney recovers from it. A study comparing long-term outcomes found that recipients whose kidneys fully recovered from delayed graft function achieved five-year GFR levels close to those of recipients who never had it in the first place (about 62 versus 66 mL/min), while those with incomplete recovery were stuck around 46 mL/min.11Scientific Reports. The recovery status from delayed graft function can predict long-term outcome after deceased donor kidney transplantation The speed and completeness of recovery reflects the balance between how much injury the kidney sustained and how well it can repair itself.12PubMed Central. Risk factors and outcomes of prolonged recovery from delayed graft function after deceased kidney transplantation
If your kidney was slow to start, a lower early GFR is expected. The key question your team is watching is whether the number keeps climbing in those early months.
The GFR Trajectory After Year One
A snapshot GFR at one year is useful, but the trend over time is a more powerful predictor of how things will go. Current modeling of post-transplant kidney function recognizes that GFR follows a nonlinear pattern: there is an initial recovery and stabilization phase in the first months, after which the trajectory settles into a slow, roughly linear decline.13PubMed Central. Longitudinal estimated glomerular filtration rate (eGFR) modeling in long‐term renal function to inform clinical trial design in kidney transplantation A gradual loss of about 1 to 2 mL/min per year is considered typical for many transplant recipients, though the rate varies widely.
Research from a large single-center experience found that the decline in GFR between years one and five was a more robust predictor of long-term graft loss and mortality than the one-year GFR value alone. Recipients whose GFR dropped by more than 10, 20, or 30 mL/min during that window faced progressively higher risks of adverse outcomes.14Nephrology Dialysis Transplantation. The impact of first year eGFR and subsequent eGFR decline on kidney transplant outcomes—a single centre experience A separate large study found that a 30 percent or greater decline in GFR, which was detected in about one in ten patients, was strongly associated with subsequent graft failure and death, and outperformed other markers including acute rejection episodes.15PubMed Central. Relationship between eGFR Decline and Hard Outcomes after Kidney Transplants
The practical takeaway: do not fixate on any single GFR reading. Pay attention to the direction and speed of change. A stable GFR of 45 is far less worrying than a GFR that was 60 last year and is now 48.
How Accurately GFR Is Estimated in Transplant Recipients
The number your lab report shows is almost always an estimate, not a direct measurement. Standard GFR-estimating equations were developed for people with two native kidneys, and they do not always perform well in transplant recipients. The standard creatinine-based equation can differ from the true measured GFR by a meaningful margin. One study comparing several equations against iothalamate clearance (a gold-standard measurement) found that even the best-performing equations only placed about three-quarters of estimates within 30 percent of the actual measured value.16PubMed Central. Cystatin C enhances GFR estimating Equations in Kidney Transplant Recipients
Equations that incorporate cystatin C, a different blood marker, tend to track changes in measured GFR more closely over time, which makes them particularly useful for monitoring trends. However, immunosuppressive medications can throw off the relationship between creatinine-based and cystatin C-based estimates. Prednisone use and higher blood sugar were both linked to larger discrepancies between the two approaches, while belatacept use was associated with better agreement.17PubMed Central. Immunosuppression and transplantation-related characteristics affect the difference between eGFR equations based on creatinine compared to cystatin C in kidney transplant recipients In children, the measurement challenge is even steeper, since growth itself changes creatinine production. Pediatric-specific cystatin C equations performed better in transplanted children, with smaller bias and more accurate staging.18PubMed Central. Comparison of estimated GFR using cystatin C versus creatinine in pediatric kidney transplant recipients
The bottom line on measurement: if your estimated GFR shifts by a few points between visits, that may reflect the imprecision of the test itself rather than a real change in kidney function. Your team looks at trends over months, not individual readings.
Medications That Affect Your GFR
Tacrolimus, the backbone anti-rejection drug for most transplant recipients, is itself toxic to the kidneys at high levels. It constricts blood vessels within the kidney, and chronic exposure can lead to scarring of the small arteries, fibrosis between the tubules, and gradual loss of functional tissue.19Annals of Transplantation. Association Between Trough Level of Tacrolimus and Change in Estimated Glomerular Filtration Rate 1 Year After Living Donor Liver Transplantation This is one of the central tensions in transplant medicine: you need the drug to prevent rejection, but the drug itself slowly damages the organ it is protecting. Keeping tacrolimus levels in the right range is why your team checks trough levels so frequently.
Newer medications are also entering the picture. SGLT2 inhibitors, a class of drugs originally developed for diabetes, have shown kidney-protective effects in non-transplant patients and are now being studied in transplant recipients. Early trial data show that dapagliflozin causes an initial dip in measured GFR of about 3 to 4 mL/min, similar to the hemodynamic dip seen in native-kidney studies. This drop is not a sign of injury but rather a reduction in the pressure inside the filtering units, which is thought to be protective over time.20PubMed Central. To INFINITI and Beyond: SGLT2 Inhibitors in Kidney Transplant Patients If you start one of these drugs and your GFR dips slightly, your team will likely expect that and watch for stabilization rather than panicking.
Blood Pressure and GFR Stability
Blood pressure control is one of the most powerful levers for preserving transplant function, and the relationship is not as simple as “lower is better.” Research tracking blood pressure trajectories found that both very low and very high systolic blood pressure patterns were associated with worse graft outcomes. Recipients with a rising blood pressure trajectory had more than double the risk of composite adverse outcomes compared with those who maintained stable blood pressure.21Transplant International. Impact of Blood Pressure on Allograft Function and Survival in Kidney Transplant Recipients
Consistency matters as much as the number itself. A study measuring the proportion of time that recipients spent within their target blood pressure range found a dose-response relationship: the more time spent in range, the lower the risk of graft complications. Recipients who stayed in target 100 percent of the time had roughly half the risk compared with those who never hit their target.22PubMed. Association Between Systolic Blood Pressure Time in Target Range and Graft Outcomes in Kidney Transplant Recipients This suggests that taking your blood pressure medication consistently every day may matter as much as which specific drug you are on.
Proteinuria and Other Warning Signs Beyond GFR
GFR alone does not tell the whole story. Protein in the urine (proteinuria) is an independent red flag that carries roughly the same weight as a low GFR in predicting graft failure. One study found that proteinuria above 0.5 grams per day at one year carried a risk comparable to having a GFR below 44 mL/min.23PubMed Central. Relationship between early proteinuria and long term outcome of kidney transplanted patients from different decades of donor age When both reduced GFR and albuminuria are present, the risks compound. Research using both markers together demonstrated that combining GFR with albumin-to-creatinine ratio identifies transplant recipients at higher risk of death and graft loss more effectively than either marker alone.24Kidney International. Association of estimated glomerular filtration rate and albuminuria with mortality and graft loss in kidney transplant recipients
This is worth knowing because some transplant recipients become laser-focused on their GFR number while ignoring urine tests. If your GFR is holding steady but protein is creeping into your urine, that can signal damage that has not yet shown up as a GFR decline.
Hidden Rejection With a Normal-Looking GFR
One of the more unsettling realities of transplant medicine is that rejection can be happening inside the kidney without your GFR budging at all. Subclinical rejection is defined as histological evidence of immune-mediated injury found on a protocol biopsy, taken at a scheduled time point, in a patient whose creatinine has not risen meaningfully. It does not trigger alarms on blood work, but it is associated with the gradual development of chronic damage and, if left untreated, shorter graft survival.25American Journal of Transplantation. The Significance of Subclinical Rejection and the Value of Protocol Biopsies
This is why some transplant centers perform scheduled biopsies at fixed intervals even when everything looks fine on paper. The practice remains somewhat controversial because biopsies carry a small risk of bleeding, but the argument for them is that catching low-grade rejection early can prevent irreversible scarring. If your center offers protocol biopsies, that is the reasoning behind them.
Growing Children and the GFR Puzzle
In pediatric transplant recipients, interpreting GFR gets an extra layer of complexity. As a child grows taller and gains muscle mass, their body surface area increases, which changes how GFR is indexed. A child whose kidney function is genuinely stable might appear to have a declining GFR simply because the denominator in the calculation (body surface area) got larger. Research has found that in children who grew substantially, the body-surface-area-indexed GFR dropped more than the absolute GFR, leading to the suggestion that tracking absolute GFR (not indexed to body size) is a better way to judge whether the graft is actually deteriorating or just being outgrown.26PubMed Central. The Creeping Creatinine in a Growing Child With a Kidney Transplant: Distinguishing Progressive Graft Dysfunction From Normal Growth in Pediatric Kidney Transplant Recipients
Parents of transplanted children should ask their nephrologist to review both the indexed and absolute GFR numbers, especially during growth spurts. A “declining GFR” on the lab report might actually be good news in disguise.
What GFR Means for How You Feel
The connection between your GFR number and your day-to-day quality of life is real but not always straightforward. Many recipients with a GFR in the 40s or 50s feel essentially normal and lead active lives. But as GFR drops further, the effects become harder to ignore. Research looking at patient-reported outcomes found that transplant recipients with CKD stage 4 or 5 (GFR below 30) were about 50 percent more likely to report symptoms of depression and anxiety compared with those whose GFR stayed at 60 or above.27PubMed Central. Association of Posttransplant Kidney Function With Patient Reported Outcomes: A Single Center’s Experience Over Nearly Two Decades Whether the low GFR directly causes those symptoms or whether the anxiety of watching your transplant falter drives them is hard to untangle, but the association is strong enough that transplant teams increasingly screen for mood changes when function dips.
Nutrition plays a role in supporting graft function, too. A retrospective study found that higher daily protein intake in the early post-transplant period was associated with a meaningfully higher GFR at three months (about 67 versus 59 mL/min in the higher versus lower protein groups).28PubMed Central. Higher daily protein intake was a protective factor for graft function of kidney transplant recipients in the early post-transplant period: a retrospective cohort study This goes against the instinct many kidney patients develop before transplant, when restricting protein is standard advice to slow native kidney disease. After transplant, the metabolic demands of surgery and healing shift the equation, and adequate protein becomes protective rather than harmful. Your dietitian can help calibrate the right amount for your situation.